Medpark Congratulates BigVision Medical on Its Grand Opening: Embarking on a New Journey in Ophthalmic Artificial Intelligence

Suzhou Big Vision Medical Technology Co., Ltd.

Since its establishment, Big Vision has always been committed to empowering ophthalmic diagnosis and treatment with AI at its core, driving innovation-led development. The company has a strong research background and rich practical experience in fields such as ophthalmic imaging analysis and artificial intelligence algorithms, and has been honored to be listed onNational Ministry of Industry and Information Technology AI Medical Device Innovation Task Unveiling Outstanding Unit, and was shortlisted for2024 Suzhou City Key Core Technology "Challenge List" Project。

In the field of ophthalmic AI research and development, Big Vision has achieved remarkable results. In its early days, the company took the lead in developing the "Ophthalmic Multimodal Artificial Intelligence Analysis and Diagnosis Software System MIAS" and the world’s first "Fully Automatic Artificial Intelligence Ophthalmic Optical Coherence Tomography (OCT) BV1000 Series." Big Vision continues to overcome technical challenges and has independently developed a series of ophthalmic AI hardware devices, including vision screening instruments, dry eye detectors, and biometers. The development of new products such as fully automatic ultra-wide-field fundus cameras is also proceeding at full speed, aiming to bring more groundbreaking innovations to the ophthalmic medical industry.

At the same time, Big Vision is actively stepping onto the global stage. While achieving remarkable results in the Chinese market, it is also promoting its full range of AI ophthalmic devices in the international market, contributing technological wisdom and strength to the development of global ophthalmic healthcare. Through continuous technological innovation and international expansion, Big Vision is gradually playing an important role in the global ophthalmic field, providing solutions to urgent issues such as early diagnosis and treatment for patients with eye diseases, especially in underdeveloped regions.